Ontogenic pattern of nucleobindin-2/nesfatin-1 expression in the gastroenteropancreatic tissues and serum of Sprague Dawley rats

Regulatory Peptides

Volumn 175, Issue 1-3, 2012, Pages 61-69

  Mohan, Haneesha ^a   Unniappan, Suraj ^a  

^a YORK UNIVERSITY   (Canada)

Author keywords

Development; Insulin; Intestine; Pancreas; Stomach

Indexed keywords

HORMONE PRECURSOR; INSULIN; MESSENGER RNA; NESFATIN 1; NUCLEOBINDIN 2; PEPTIDE HORMONE; UNCLASSIFIED DRUG;

ADULT ANIMAL; AGE; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEVELOPMENTAL STAGE; DUODENUM; EMBRYO; ENTEROENDOCRINE CELL; GENE EXPRESSION; GLUCOSE METABOLISM; HORMONE RELEASE; HORMONE SYNTHESIS; IMMUNOREACTIVITY; NEWBORN; NONHUMAN; ONTOGENY; PANCREAS; PANCREAS ISLET BETA CELL; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RAT; STOMACH; TISSUE SPECIFICITY;

ANIMALS; ANIMALS, NEWBORN; BLOTTING, WESTERN; CALCIUM-BINDING PROTEINS; CELLS, CULTURED; DNA-BINDING PROTEINS; EMBRYO, MAMMALIAN; ENTEROENDOCRINE CELLS; FEMALE; GASTROINTESTINAL TRACT; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GLUCOSE; IMMUNOENZYME TECHNIQUES; INSULIN; ISLETS OF LANGERHANS; NERVE TISSUE PROTEINS; PANCREAS; RATS; RATS, SPRAGUE-DAWLEY; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

RATTUS;

EID: 84858337528     PISSN: 01670115     EISSN: 18731686     Source Type: Journal    
DOI: 10.1016/j.regpep.2012.02.006     Document Type: Article

References (37)

1. Oh-I S., Shimizu T., Satoh T., Okada S., Adachi S., Inoue K., Eguchi H., Yamamoto M., Imaki T., Hashimoto K., Tsuchiya T., Monden T., Horiguchi K., Yamada M., Mori M. Identification of nesfatin-1 as a satiety molecule in the hypothalamus. Nature 2006, 443:709-712.
2. Myers M.G. Keeping the fat off with nesfatin. Nat Med 2006, 12:1248-1249.
3. Cowley M.A., Grove K.L. To be or NUCB2, is nesfatin the answer?. Cell Metab 2006, 4:421-422.
4. Steiner D.F., James D.E. Cellular and molecular biology of the beta cell. Diabetologia 1992, 35:S41-S48.
5. Yosten G.L., Samson W.K. The anorexigenic and hypertensive effects of nesfatin-1 are reversed by pretreatment with an oxytocin receptor antagonist. Am J Physiol Regul Integr Comp Physiol 2010, 298:R1642-R1647.
6. Brailoiu G.C., Dun S.L., Brailoiu E., Inan S., Yang J., Chang J.K., Dun N.J. Nesfatin-1: distribution and interaction with a G protein-coupled receptor in the rat brain. Endocrinology 2007, 148:5088-5094.
7. Foo K., Brismar H., Broberger C. Distribution and neuropeptide coexistence of nucleobindin-2 mRNA/nesfatin-like immunoreactivity in the rat CNS. Neuroscience 2008, 156:563-579.
8. Kohno D., Nakata M., Maejima Y., Shimizu H., Sedbazar U., Yoshida N., Dezaki K., Onaka T., Mori M., Yada T. Nesfatin-1 neurons in paraventricular and supraoptic nuclei of the rat hypothalamus coexpress oxytocin and vasopressin and are activated by refeeding. Endocrinology 2007, 149:1295-1300.
9. Stengel A., Goebel M., Yakubov I., Wang L., Witcher D., Coskun T., Tache Y., Sachs G., Lambrecht N.W. Identification and characterization of nesfatin-1 immunoreactivity in endocrine cell types of the rat gastric oxyntic mucosa. Endocrinology 2009, 150:232-238.
10. Zhang A.Q., Li X.L., Jiang C.Y., Lin L., Shi R.H., Chen J.D., Oomura Y. Expression of nesfatin-1/NUCB2 in rodent digestive system. World J Gastroenterol 2010, 16:1735-1741.
11. Gonzalez R., Tiwari A., Unniappan S. Pancreatic beta cell colocalize insulin and pronesfatin immunoreactivity in rodents. Biochem Biophys Res Commun 2009, 381:643-648.
12. Foo K.S., Brauner H., Ostenson C.G., Broberger C. Nucleobindin-2/nesfatin in the endocrine pancreas: distribution and relationship to glycaemic state. J Endocrinol 2010, 204:255-263.
13. Shimizu H., Oh-I S., Hashimoto K., Nakata M., Yamamoto S., Yoshida N., Eguchi H., Kato I., Inoue K., Satoh T., Okada S., Yamada M., Yada T., Mori M. Peripheral administration of nesfatin-1 reduced food intake in mice: the leptin-independent mechanism. Endocrinology 2009, 150:662-671.
14. Stengel A., Goebel M., Wang L., Rivier J., Kobelt P., Monnikes H., Lambrecht N.W., Tache Y. Central nesfatin-1 reduces dark-phase food intake and gastric emptying in rats: differential role of corticotropin-releasing factor2 receptor. Endocrinology 2009, 150:4911-4919.
15. Goebel M., Stengal A., Wang L., Tache Y. Central nesfatin-1 reduces the nocturnal food intake in mice by reducing meal size and increasing inter-meal intervals. Peptides 2011, 32:36-43.
16. Atsuchi K., Asakawa A., Ushikai M., Ataka K., Tsai M., Koyama K., Sato Y., Kato I., Fujimiya M., Inui A. Centrally administered nesfatin-1 inhibits feeding behaviour and gastroduodenal motility in mice. Neuroreport 2010, 21:1008-1011.
17. Maejima Y., Sedbazar U., Suyama S., Kohno D., Onaka T., Takano E., Yoshida N., Koike M., Uchiyama Y., Fujiwara K., Yashiro T., Horvath T.L., Dietrich M.O., Tanaka S., Dezaki K., Oh-I S., Hashimoto K., Shimizu H., Nakata M., Mori M., Yada T. Nesfatin-1-regulated oxytocinergic signaling in the paraventricular nucleus causes anorexia through a leptin-independent melanocortin pathway. Cell Metab 2009, 10:355-365.
18. Gonzalez R., Perry L.S., Gao X., Gaidhu M.P., Tsushima R.G., Ceddia R.B., Unniappan S. Nutrient responsive nesfatin-1 regulates energy balance and induces glucose-stimulated insulin secretion in rats. Endocrinology 2011, 152:3628-3637.
19. Gonzalez R., Reingold B.K., Gao X., Gaidhu M.P., Tsushima R.G., Unniappan S. Nesfatin-1 exerts a direct, glucose-dependent insulinotropic action on mouse islet beta- and MIN6 cells. J Endocrinol 2011, 208:R9-R16.
20. Su Y., Zhang J., Tang Y., Bi F., Liu J.N. The novel function of nesfatin-1: anti-hyperglycemia. Biochem Biophys Res Commun 2010, 391:1039-1042.
21. Li Q.C., Wang H.Y., Chen X., Guan H.Z., Jiang Z.Y. Fasting plasma levels of nesfatin-1 in patients with type 1 and type 2 diabetes mellitus and the nutrient-related fluctuation of nesfatin-1 level in normal humans. Regul Pept 2010, 159:72-77.
22. Gonzalez R., Kerbel B., Gao X., Chun A., Unniappan S. Molecular, cellular and physiological evidence for the anorexigenic actions of nesfatin-1 in goldfish. PLoS One 2010, 5:e15201.
23. Kerbel B., Unniappan S. Nesfatin-1 suppresses energy intake, co-localises ghrelin in the brain and gut, and alters ghrelin, cholecystokinin and orexin mRNA expression in goldfish. J Neuroendocrinol 2011, 24:366-377.
24. Oliver P., Pico C., De Matteis R., Cinti S., Palou A. Perinatal expression of leptin in rat stomach. Dev Dyn 2002, 223:148-154.
25. Chanoine J.P., Wong A.C.K. Ghrelin gene expression is markedly higher in fetal pancreas compared with fetal stomach: effect of maternal fasting. Endocrinology 2004, 145:3813-3820.
26. Cunha D.A., Amaral M.E.C., Carvalho C.P.F., Collares-Buzato C.B., Carneiro E.M., Boschero A.C. Increased expression of SNARE proteins and synaptotagmin IV in islets from pregnant rats and in vitro prolactin-treated neonatal islets. Biol Res 2006, 39:555-556.
27. Hanash S.M. Biomedical applications of two-dimensional electrophoresis using immobilized pH gradients: current status. Electrophoresis 2000, 21:1202-1209.
28. Boyanton B.L., Blick K.E. Stability studies of twenty-four analytes in human plasma and serum. Clin Chem 2002, 48:2242-2247.
29. Walia P., Asadi A., Kieffer T.J., Johnson J.D., Chanoine J.P. Ontogeny of ghrelin, obestatin, preproghrelin, and prohormone convertases in rat pancreas and stomach. Pediatr Res 2009, 65:39-44.
30. Hendy G.N., Bevan S., Mattei M.G., Mouland A.J. Chromogranin A. Clin Invest Med 1995, 18:47-65.
31. Krause W.J. Brunner's glands: a structural, histochemical and pathological profile. Prog Histochem Cytochem 2000, 35:259-367.
32. King J.C. Maternal obesity, metabolism and pregnancy outcomes. Annu Rev Nutr 2006, 26:271-291.
33. Navarro-Tableros V., Fiordelisio T., Hernandez-Cruz A., Hiriart M. Physiological development of insulin secretion, calcium channels, and GLUT2 expression of pancreatic rat beta-cells. Am J Physiol Endocrinol Metab 2007, 292:E1018-E1029.
34. Asplund K. Dynamics of insulin release from the foetal and neonatal rat pancreas. Eur J Clin Invest 1973, 3:338-344.
35. Hole R., Pian Smith M., Sharp G. Development of the biphasic response to glucose in fetal and neonatal rat pancreas. Am J Physiol 1988, 254:E167-E174.
36. Weinhaus A., Poronnik P., Cook D., Tuch B. Insulin secretagogues, but not glucose, stimulate an increase in [Ca++]i in the fetal rat beta-cell. Diabetes 1995, 44:118-124.
37. Aguayo-Mazzucato C., Sanchez-Soto C., Godinez-Puig V., Gutierrez-Ospina G., Hiriant M. Restructuring of pancreatic islets and insulin secretion in a postnatal critical window. PLoS One 2006, 1:e35.